Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COMy Virtual 2020 | The Turkish COVID-19 clinical experience

Meral Beksac • 13 May 2020
COMy Virtual 2020

Meral Beksac, MD, Ankara University, Ankara, Turkey, provides us with an outline of the COVID-19 experience in Turkey. Specifically mentioned is the BCG vaccine and the low incidence and mortality rates in Turkey. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Meral Beksac

Insights into the development of the Turkish Myeloma Study Group's 2026 treatment guidelines
2:36
Insights into the development of the Turkish Myeloma Study Group's 2026 treatment guidelines
Meral Beksac • 23 Sep 2026
Clinical characteristics of a dual-center cohort of patients with MM surviving more than 15 years
3:27
Clinical characteristics of a dual-center cohort of patients with MM surviving more than 15 years
Meral Beksac • 23 Sep 2026
Early relapse score for identifying functionally high-risk myeloma across cytogenetic subgroups
3:48
Early relapse score for identifying functionally high-risk myeloma across cytogenetic subgroups
Meral Beksac • 24 Mar 2026
Results from the Phase II EMN19 study: Dara-VCd in patients with extramedullary myeloma
2:29
Results from the Phase II EMN19 study: Dara-VCd in patients with extramedullary myeloma
Meral Beksac • 24 Mar 2026
The content of VJHemOnc is intended for healthcare professionals